Serum IgE levels after bone marrow transplantation.

Area of Science:

• Immunology
• Hematology
• Transplantation Medicine

Background:

• Serum immunoglobulin E (IgE) levels can fluctuate after bone marrow transplantation (BMT).
• Understanding post-transplant IgE dynamics is crucial for clinical significance.
• Pre-transplant IgE levels may influence post-transplant responses.

Purpose of the Study:

• To investigate the clinical significance of monitoring total serum IgE levels in bone marrow transplant recipients.
• To correlate serum IgE changes with engraftment, graft-versus-host disease (GVHD), infections, and conditioning regimens.

Main Methods:

• Total serum IgE levels were monitored in 135 bone marrow transplant recipients.
• IgE levels were analyzed in relation to pre-transplant levels, engraftment, acute and chronic GVHD, infections, and re-transplantation.
• Correlations with CD4+/CD8+ cell ratios were assessed.

Main Results:

• Elevated IgE levels post-BMT were observed in 59% of patients with pre-transplant IgE < 60 U/ml, while 16% with pre-transplant IgE ≥ 60 U/ml showed decreasing levels.
• IgE increases coincided with engraftment and acute GVHD (p<0.01).
• Multiple IgE peaks were more common in grades II-IV GVHD (p<0.001), and IgE elevation was mainly attributed to conditioning treatment, not infections or chronic GVHD.

Conclusions:

• Serum IgE elevation after BMT is associated with engraftment and acute GVHD.
• Conditioning treatment appears to be the primary driver of post-transplant IgE elevation.
• Serum IgE monitoring may provide insights into BMT complications, but is not directly correlated with CD4+/CD8+ cell counts.